"Creating Innovative Solutions for Better Health Outcomes"
Akilaya Pharmaceuticals is providing pharmaceutical solutions like Development, Manufacturing, Technology Transfers and Site transfers to various pharmaceutical firms across India.
Our manufacturing portfolio includes a whole range of pharmaceutical preparations like liquid injectables, Lyophilized injectable vials, prefilled syringes, ophthalmic vials, tablets, hard gelatin capsules, soft gelatin capsules. We can manufacture Hormonal, potent and general category drugs.
Our strong knowledge of the industry and experienced team of professionals are second to none. We are committed to providing our customers with the highest quality products, and our production process is highly ethical and strictly regulated. We strive to ensure that our customers receive the best possible results, and our commitment to excellence is unmatched.
With Akilaya Pharmaceuticals, you can be rest assured that you are receiving the best possible service and products.
Our brand new Pharmaceutical and Nutraceutical Manufacturing plant at Madhanandapuram, Chennai allows you to access world class manufacturing services at affordable rates. We adhere to international standards and have long term clients who trust our services. Our team of experienced professionals understand the importance of quality and consistency and strive to provide the highest quality products. Our state-of-the-art facilities are equipped with the latest technology and quality assurance systems, enabling us to provide consistent, reliable and cost-effective services.
We specialize in custom formulations. We use our extensive research and development capabilities to create custom formulations tailored to the specific needs of our customers. We understand that no two customers are the same, and our custom formulations reflect that.
For pharmaceutical manufacturers, technology transfer is essential in ensuring that their products are manufactured according to the highest standards of quality and safety. Proper technology transfer also helps ensure that products are consistent, compliant with relevant regulations, and cost-effective. We have a tried and tested methodology for transfer of documents, processes, and personnel, which includes training, validation, and process optimization as well.
We manufacture small volume parenterals which include liquid injectables in ampoules and vials ranging from 1 ML to 100 ML with lyophilisation capability, prefilled syringes and ophthalmic vials. The sterile manufacturing area and primary packaging area are class A as per the classification norms. The sterile facility consists of three vial lines from Sterile Line Italy with two tofflon lyopphilizers, one ampoule line from ROTA Germany, Prefilled syringe line from Turkey and a ophthalmic vial line from Turkey. ROTA line is capable of filling ampoules and vials with a fill volume ranging from 1 ML to 10 ML. This fully integrated line consists of washing, drying, de-pyrogenating, filling, stoppering and ampoule sealing and labelling.
This block is dedicated for oral solid dosage forms of general category drugs. We manufacture tablets and hard gelatin capsules in this block. Some of the manufacturing machines in this block include Sejong capsule filling machine, Cadmac compression machines, HATA compression machine, Rapid pack Blister packing machines, BQS Alu Alu packing machine and a bottle packing line from Parle.
We have a Jekson serialization machine for your serialization needs. The tableting and hard gelatin capsule core manufacturing areas and the primary packaging area are class D as per the requisite classification norms.
We verify all incoming raw materials through identity, purity and quality checks before they enter production. During manufacturing, in-process samples are continuously monitored to ensure that each step meets defined specifications, preventing deviations and ensuring batch uniformity.
We maintain consistent accuracy through regular calibration of analytical instruments and periodic performance checks. All testing methods are validated for precision, accuracy, specificity, and reproducibility, ensuring reliable and scientifically sound results every time
All QC operations follow strict Good Laboratory Practices (GLP) with emphasis on accuracy, traceability, and transparent reporting. Electronic records, audit trails, and standardized documentation systems help ensure complete data integrity and regulatory compliance
Our QC team conducts real-time and accelerated stability studies to evaluate product performance under various environmental conditions. These studies help determine shelf-life, storage requirements, and overall product integrity throughout its lifecycle
Every batch of finished product undergoes comprehensive analytical, physical, and microbiological testing. Our team ensures compliance with pharmacopeial standards and stability expectations before products are approved for market release.

Our biotech research is focused on replacing existing chemical methods of manufacturing various intermediates, with fermentation and enzymatic based transformations to improve environmental safety.
Capabilities include:

Our pre-clinical facility (PCF) undertakes a wide range of studies, including regulatory toxicity – which are required for filing Investigational New Drug (IND) applications. A number of new screening facilities and biological evaluation models have been set up to support the drug discovery and development process.
A wide range of animal toxicology, microbiology and pharmacology studies are also undertaken to confirm the safety and efficacy of molecules. The facility is registered with the committee for the Purpose of Control and Supervision of Experiment on Animals (CPCSEA), Ministry of Environment & Forests and the Government of India. Additionally, an Institutional Animal Ethics Committee (IAEC) monitors our research for issues related to animal welfare and experimentation. Work quality standards are in compliance with US Food Drug Administration (US FDA) and the Organization for Economic Co-operation Development (OECD) principles of Good Laboratory Practice (GLP).

Pioneering research to devise newer strategies for effectively delivering the drugs in the body or improvise the existing technologies to enhance their efficiency is the need of the hour. The ever improving delivery systems are not only beneficial to the patients as they are less cumbersome and easy to abide by but also reduce the complications associated with the induction of the drug in the body.
At Akilaya Pharmaceuticals, we focus on developing novel drug delivery systems (NDDS) for select anti-infective molecules. A few platform and product specific technologies with six prototype formulations have been successfully developed.
Areas of NDDS Research
To be a global manufacturing company providing value-added end to end solutions to Pharmaceutical companies.
To become an one stop shop for manufacturing high quality medicines and provide end to end solutions to pharmaceutical companies across the globe enabling them to focus on getting medicines to patients everywhere
Have questions, inquiries, or business requirements? We’d be glad to assist you. Contact us today, and our team will get back to you at the earliest.
enquiry@akilayapharmaceuticals.com
+91 44 2482 6367 / +91 94445 87218
Address:No.29, 9th Cross Street, Annai Velankanni Nagar, Madhanandapuram, Chennai, Tamil Nadu - 600125:
Open today | 09:00 am – 05:00 pm |

Copyright © 2026 Akilaya PHARMACEUTICALS - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.